Linked Life Data

1655769

Source:http://linkedlifedata.com/resource/pubmed/id/1655769

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1655769rdf:typepubmed:Citationlld:pubmed
pubmed-article:1655769lifeskim:mentionsumls-concept:C0596901lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C0082529lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C1519726lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C0129533lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C0597876lld:lifeskim
pubmed-article:1655769lifeskim:mentionsumls-concept:C0070750lld:lifeskim
pubmed-article:1655769pubmed:issue28lld:pubmed
pubmed-article:1655769pubmed:dateCreated1991-11-8lld:pubmed
pubmed-article:1655769pubmed:abstractTextEngagement of membrane IgM on a number of human and murine B-cell lines induced activation of a Mn(2+)-preferring serine/threonine kinase that phosphorylated microtubule-associated protein-2 (MAP-2) in vitro. B-cell MAP-2 kinase (MAP-2K) activity could be fractionated into two peaks by sequential DEAE and hydrophobic chromatography. Although peak I included two tyrosine phosphoproteins of molecular mass 36 and 38 kDa, peak II showed a single 42-kDa tyrosine phosphoprotein (pp42). Since all kinase activity could be removed from peak II material over an antiphosphotyrosine immune affinity column, it suggests that pp42 is identical with lymphoid MAP-2K. Although peak I activity showed a similarity to peak II with regard to its preference for Mn2+, sensitivity to phosphatase exposure, and resistance to a range of common serine kinase inhibitors, it is not clear whether these activities are related. MAP-2 kinase activity could also be induced by treatment with the phorbol ester, phorbol myristate 13-acetate, suggesting that protein kinase C may also be involved with MAP-2K regulation. Although MAP-2K activity reached a peak response within minutes of receptor ligation, there were differences in the rates of dephosphorylation of pp42 and decline of MAP-2K activity in different B-cell lines. The tyrosine phosphatase inhibitor, vanadate, transformed a rapidly reversible MAP-2K response in BAL 17.2 cells into a sustained state of activation that resembled the kinetics of activation in WEHI-231 cells. The latter finding implies involvement of a tyrosine phosphatase, which opposes the effect of an inducing tyrosine kinase.lld:pubmed
pubmed-article:1655769pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:languageenglld:pubmed
pubmed-article:1655769pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:citationSubsetIMlld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1655769pubmed:statusMEDLINElld:pubmed
pubmed-article:1655769pubmed:monthOctlld:pubmed
pubmed-article:1655769pubmed:issn0021-9258lld:pubmed
pubmed-article:1655769pubmed:authorpubmed-author:WilliamsKKlld:pubmed
pubmed-article:1655769pubmed:authorpubmed-author:KatzRRlld:pubmed
pubmed-article:1655769pubmed:authorpubmed-author:NelA EAElld:pubmed
pubmed-article:1655769pubmed:authorpubmed-author:CasillasAAlld:pubmed
pubmed-article:1655769pubmed:authorpubmed-author:HanekomCClld:pubmed
pubmed-article:1655769pubmed:issnTypePrintlld:pubmed
pubmed-article:1655769pubmed:day5lld:pubmed
pubmed-article:1655769pubmed:volume266lld:pubmed
pubmed-article:1655769pubmed:ownerNLMlld:pubmed
pubmed-article:1655769pubmed:authorsCompleteYlld:pubmed
pubmed-article:1655769pubmed:pagination19088-94lld:pubmed
pubmed-article:1655769pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:meshHeadingpubmed-meshheading:1655769-...lld:pubmed
pubmed-article:1655769pubmed:year1991lld:pubmed
pubmed-article:1655769pubmed:articleTitleStimulation of B-cells via the membrane immunoglobulin receptor or with phorbol myristate 13-acetate induces tyrosine phosphorylation and activation of a 42-kDa microtubule-associated protein-2 kinase.lld:pubmed
pubmed-article:1655769pubmed:affiliationDepartment of Medicine, UCLA School of Medicine 90024-1680.lld:pubmed
pubmed-article:1655769pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1655769pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1655769pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1655769lld:pubmed